W. Nooijen

发表

Radiation injury in the human kidney: a prospective analysis using specific scintigraphic and biochemical endpoints.

L. Dewit, C. Hoefnagel, J. K. Anninga, 1990, International journal of radiation oncology, biology, physics.

Comparative pharmacology of the novel cyclopropylpyrroloindole-prodrug carzelesin in mice, rats, and humans.

J. Beijnen, L. Schaaf, O. van Tellingen, 1998, Cancer research.

Phase I trial of combined immunotherapy with subcutaneous granulocyte macrophage colony-stimulating factor, low-dose interleukin 2, and interferon alpha in progressive metastatic melanoma and renal cell carcinoma.

M. Kersten, J. Sein, F. Vyth-Dreese, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Enhanced oral bioavailability of paclitaxel in mice treated with the P-glycoprotein blocker SDZ PSC 833.

J. Beijnen, P. Borst, A. Sparreboom, 1997, British Journal of Cancer.

Increased oral bioavailability of paclitaxel by GF120918 in mice through selective modulation of P-glycoprotein.

J. Schellens, H. Rosing, J. Beijnen, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Rapid esterase-sensitive breakdown of polysorbate 80 and its impact on the plasma pharmacokinetics of docetaxel and metabolites in mice.

J. Verweij, J. Beijnen, A. Sparreboom, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Cremophor EL causes (pseudo-) non-linear pharmacokinetics of paclitaxel in patients

J. Schellens, J. Beijnen, J. Schellens, 1999, British Journal of Cancer.

Temozolomide followed by combined immunotherapy with GM-CSF, low-dose IL2 and IFNα in patients with metastatic melanoma

M. Kersten, J. Sein, W. Boogerd, 2003, British Journal of Cancer.

Determination of paclitaxel and metabolites in mouse plasma, tissues, urine and faeces by semi-automated reversed-phase high-performance liquid chromatography.

J. Beijnen, A. Sparreboom, O. van Tellingen, 1995, Journal of chromatography. B, Biomedical applications.

Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine.

J. Beijnen, P. Borst, A. Sparreboom, 1997, Proceedings of the National Academy of Sciences of the United States of America.

Plasma pharmacokinetics, tissue disposition, excretion and metabolism of vinorelbine in mice as determined by high performance liquid chromatography

J. Beijnen, O. Tellingen, W. Nooijen, 1993, Investigational New Drugs.

Plasma pharmacokinetics, tissue disposition, excretion and metabolism of vinleucinol in mice as determined by high-performance liquid chromatography

J. Beijnen, O. Tellingen, W. Nooijen, 2004, Cancer Chemotherapy and Pharmacology.

Plasma pharmacokinetics of vinblastine and the investigational Vinca alkaloid N-(deacetyl-O-4-vinblastoyl-23)-L-ethyl isoleucinate in mice as determined by high-performance liquid chromatography.

J. Beijnen, O. van Tellingen, W. Nooijen, 1993, Cancer research.

Phase I Clinical Study With Multiple Peptide Vaccines in Combination With Tetanus Toxoid and GM-CSF in Advanced-stage HLA-A*0201-positive Melanoma Patients

J. Haanen, J. Sein, F. Vyth-Dreese, 2007, Journal of immunotherapy.

Impaired mitochondrial respiration and stimulated glycolysis by m‐iodobenzylguanidine (mibg)

A. Meijer, W. Nooijen, L. Smets, 1990, International journal of cancer.

Preclinical pharmacokinetics of paclitaxel and docetaxel.

J. Beijnen, A. Sparreboom, O. van Tellingen, 1998, Anti-cancer drugs.

The vascular compartment hampers accurate determination of teniposide penetration into brain tumor tissue

J. Beijnen, O. van Tellingen, W. Boogerd, 1997, Cancer Chemotherapy and Pharmacology.

Altered pharmacokinetics of vinblastine in Mdr1a P-glycoprotein-deficient Mice.

J. Beijnen, P. Borst, O. van Tellingen, 1996, Journal of the National Cancer Institute.

Second line endocrine treatment of postmenopausal advanced breast cancer. Preliminary endocrine results of a 5-ARM randomized phase II trial of medium vs low dose aminoglutethimide, with or without hydrocortisone vs hydrocortisone alone (EORTC 10861)

J. Schornagel, J. Jassem, W. Nooijen, 1990, The Journal of Steroid Biochemistry and Molecular Biology.

Low dose aminoglutethimide without hydrocortisone for the treatment of advanced postmenopausal breast cancer.

A. Hart, P. Bruning, W. Nooijen, 1989, European journal of cancer & clinical oncology.

High-dose carboplatin, thiotepa and cyclophosphamide (CTC) with peripheral blood stem cell support in the adjuvant therapy of high-risk breast cancer: a practical approach.

S. Rodenhuis, J. Baars, D. Richel, 1995, British Journal of Cancer.

Bone marrow reconstitution after high-dose chemotherapy and autologous peripheral blood progenitor cell transplantation: effect of graft size.

S. Rodenhuis, O. Dalesio, D. Richel, 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

Feasibility of multiple courses of high-dose cyclophosphamide, thiotepa, and carboplatin for breast cancer or germ cell cancer.

S. Rodenhuis, J. Baars, J. Schornagel, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Isolation, purification and biological activity of major docetaxel metabolites from human feces.

J. Beijnen, A. Sparreboom, O. van Tellingen, 1996, Drug metabolism and disposition: the biological fate of chemicals.

Infiltration of activated dendritic cells and T cells in renal cell carcinoma following combined cytokine immunotherapy.

D. de Jong, W. Meinhardt, S. Horenblas, 2005, European urology.

At home management of aplastic phase following high-dose chemotherapy with stem-cell rescue for hematological and non-hematological malignancies.

S. Rodenhuis, J. Schornagel, A. Westermann, 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

Immunotherapy with concurrent subcutaneous GM-CSF, low-dose IL-2 and IFN-α in patients with progressive metastatic renal cell carcinoma

M. Kersten, G. Groenewegen, S. Horenblas, 2003, British Journal of Cancer.

Lack of anti‐tumour reactivity despite enhanced numbers of circulating natural killer T cells in two patients with metastatic renal cell carcinoma

J. Haanen, J. Sein, A. Bex, 2010, Clinical and experimental immunology.

Reinfusion of autologous lymphocytes with granulocyte-macrophage colony-stimulating factor induces rapid recovery of CD4+ and CD8+ T cells after high-dose chemotherapy for metastatic breast cancer.

S. Rodenhuis, J. Schornagel, J. Sein, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Isolation, purification, and biological activity of mono- and dihydroxylated paclitaxel metabolites from human feces

J. Beijnen, A. Sparreboom, O. Tellingen, 1995, Cancer Chemotherapy and Pharmacology.

Pharmacology, bio-analysis and pharmacokinetics of the vinca alkaloids and semi-synthetic derivatives (review).

J. Beijnen, O. van Tellingen, W. Nooijen, 1992, Anticancer research.

Determination of polyoxyethyleneglycerol triricinoleate 35 (Cremophor EL) in plasma by pre-column derivatization and reversed-phase high-performance liquid chromatography.

J. Beijnen, A. Sparreboom, O. van Tellingen, 1996, Journal of chromatography. B, Biomedical applications.

Sex pheromones of the american cockroach, : a tentative structure of periplanone-B

W. Nooijen, C. Persoons, F. J. Ritter, 1976 .

Monitoring Very Low Levels of AFP in the Early Detection of Tumor Recurrency

T. Out, P. Bruning, W. Nooijen, 1984 .

Immunogenicity, including vitiligo, and feasibility of vaccination with autologous GM-CSF-transduced tumor cells in metastatic melanoma patients.

A. Berns, M. Gallee, W. Mooi, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Tissue disposition, excretion and metabolism of vinblastine in mice as determined by high-performance liquid chromatography

J. Beijnen, O. Tellingen, W. Nooijen, 2004, Cancer Chemotherapy and Pharmacology.

Thyroid function 10-18 years after mantle field irradiation for Hodgkin's disease.

W. Nooijen, R. Melkert, P. Bruning, 1992, European journal of cancer.

Nonlinear pharmacokinetics of paclitaxel in mice results from the pharmaceutical vehicle Cremophor EL.

J. Beijnen, A. Sparreboom, O. van Tellingen, 1996, Cancer research.

Tissue distribution, metabolism and excretion of paclitaxel in mice

J. Beijnen, A. Sparreboom, O. van Tellingen, 1996, Anti-cancer drugs.

Recalculation of calcium-binding properties of human and rat fibrin(ogen) and their degradation products.

W. Nieuwenhuizen, F. Haverkate, W. Nooijen, 1981, Thrombosis research.

Calcium‐binding properties of human fibrin(ogen) and degradation products

W. Nieuwenhuizen, F. Haverkate, W. Nooijen, 1979, FEBS letters.

Randomised trial of high-dose chemotherapy and haemopoietic progenitor-cell support in operable breast cancer with extensive axillary lymph-node involvement

J. Peterse, S. Rodenhuis, J. Baars, 1998, The Lancet.

Insulin resistance and breast‐cancer risk

A. A. Hart, P. V. van Noord, P. Bruning, 1992, International journal of cancer.

The pharmacokinetics of reduced folates after intraperltoneal and intravenous administration of racemic [6S,R]-folinic acid

S. Rodenhuis, J. Beijnen, O. Tellingen, 2004, Cancer Chemotherapy and Pharmacology.

A clinical pharmacokinetics study of carzelesin given by short-term intravenous infusion in a phase I study

M. Piccart, J. Beijnen, L. Schaaf, 1998, Cancer Chemotherapy and Pharmacology.

Body measurements, estrogen availability and the risk of human breast cancer: A case‐control study

J. Battermann, A. A. Hart, P. V. van Noord, 1992, International journal of cancer.

Sex pheromone of the beet armyworm, Spodoptera exigua: isolation, identification and preliminary field evaluation

T. Baker, W. Nooijen, C. Persoons, 1981 .

A simple method for the measurement of the steroid fraction bound to sex hormone binding globulin in serum.

P. Bruning, W. Nooijen, J. Bonfrer, 1989, Journal of steroid biochemistry.

High-performance liquid chromatographic bio-analysis of PSC 833 in human and murine plasma.

J. Beijnen, O. van Tellingen, W. Nooijen, 1998, Journal of chromatography. B, Biomedical sciences and applications.

Immunogenicity and bioactivity of glucagon, modified at methionine-27.

H. Kempen, W. Nooijen, 1979, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Radioimmunoassay for Pancreatic Glucagon Based on Specific Derivatisation of the Hormone

W. Nooijen, P. Koppert, 1981, Annals of clinical biochemistry.

Cremophor EL causes (pseudo-) non-linear pharmacokinetics of paclitaxel in patients

J. Beijnen, J. Schellens, O. Tellingen, 1999, British Journal of Cancer.